Indaptus Therapeutics GAAP EPS of -$0.46 beats by $0.45

• Indaptus Therapeutics press release (NASDAQ:INDP): Q2 GAAP EPS of -$0.46 beats by $0.45.
• As of June 30, 2022, the Company had cash, cash equivalents and short-term investments of approximately $33.0 million. As of December 31, 2021, the Company had cash and cash equivalents of approximately $39.1 million.